Status:
RECRUITING
Prevalence of the c.853delT Mutation of the HOXB13 Gene in Prostate Cancer in Martinique
Lead Sponsor:
University Hospital Center of Martinique
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
In Martinique, prostate cancer incidence rates are nowadays among the highest worldwide with a high incidence of early-onset and familial forms. We identified a rare heterozygous germline variant c.85...
Detailed Description
In Martinique, prostate cancer incidence rates are nowadays among the highest worldwide with a high incidence of early-onset and familial forms. Despite the demonstration of a strong familial componen...
Eligibility Criteria
Inclusion
- Adult man over 18 years of age living in Martinique with a prostate cancer whatever the histological type and the stage, managed in urology consultation (public and private sectors of Martinique)
- Sporadic or familial form
- Informed with a written consent signed by the participant and the investigator
- Affiliate or beneficiary of french social security.
Exclusion
- Patient who is not of African descent
- Refusal to participate.
- Patients not affiliated to french social security
Key Trial Info
Start Date :
April 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 9 2025
Estimated Enrollment :
465 Patients enrolled
Trial Details
Trial ID
NCT05231915
Start Date
April 9 2021
End Date
April 9 2025
Last Update
August 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Martinique
Fort-de-France, Martinique, 97261